Secondary |
Hypertension |
31.5% |
Ill-defined Disorder |
10.5% |
Dyslipidaemia |
9.7% |
Atrial Fibrillation |
8.1% |
Diabetes Mellitus |
8.1% |
Colitis Ulcerative |
5.6% |
Coronary Artery Disease |
5.6% |
Gout |
4.0% |
Oedema Peripheral |
4.0% |
Pain In Extremity |
4.0% |
Peripheral Arterial Occlusive Disease |
4.0% |
Renal Impairment |
4.0% |
Arthralgia |
0.8% |
|
Pancytopenia |
33.3% |
Renal Failure Acute |
20.0% |
Hyperkalaemia |
13.3% |
Type 1 Diabetes Mellitus |
13.3% |
Vomiting |
13.3% |
Renal Failure |
6.7% |
|
Concomitant |
Product Used For Unknown Indication |
20.4% |
Hypertension |
18.6% |
Rheumatoid Arthritis |
6.8% |
Cardiac Failure |
6.3% |
Cardiac Failure Chronic |
6.0% |
Pulmonary Arterial Hypertension |
4.7% |
Diabetes Mellitus |
4.2% |
Ill-defined Disorder |
3.7% |
Atrial Fibrillation |
3.4% |
Coronary Artery Disease |
3.1% |
Drug Use For Unknown Indication |
3.1% |
Pain |
3.1% |
Chronic Obstructive Pulmonary Disease |
2.9% |
Thrombosis Prophylaxis |
2.6% |
Heart Transplant |
2.4% |
Prophylaxis |
2.1% |
Oedema |
1.8% |
Chronic Lymphocytic Leukaemia |
1.6% |
Colorectal Cancer Metastatic |
1.6% |
Gastric Cancer |
1.6% |
|
Death |
15.9% |
Sepsis |
7.9% |
Cardiac Failure |
6.3% |
Enterocolitis |
6.3% |
Vomiting |
6.3% |
Cerebrovascular Accident |
4.8% |
Clostridium Difficile Colitis |
4.8% |
Renal Failure |
4.8% |
Renal Failure Acute |
4.8% |
Speech Disorder |
4.8% |
Thrombocytopenia |
4.8% |
Angina Pectoris |
3.2% |
Cardiopulmonary Failure |
3.2% |
Concomitant Disease Progression |
3.2% |
Dermatitis Allergic |
3.2% |
Dyspnoea |
3.2% |
Impaired Healing |
3.2% |
Ischaemic Stroke |
3.2% |
Loss Of Consciousness |
3.2% |
Oedema Peripheral |
3.2% |
|
Interacting |
Hypertension |
31.0% |
Diabetes Mellitus |
13.8% |
Atrial Fibrillation |
10.3% |
Dyslipidaemia |
10.3% |
Colitis Ulcerative |
6.9% |
Coronary Artery Disease |
6.9% |
Gout |
5.2% |
Peripheral Arterial Occlusive Disease |
5.2% |
Oedema Peripheral |
3.4% |
Pain In Extremity |
3.4% |
Renal Impairment |
3.4% |
|
Renal Failure Acute |
42.9% |
Hepatocellular Injury |
28.6% |
Pancytopenia |
28.6% |
|